Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Future Market

Overheard at the J.P. Morgan Healthcare Conference

Executives detailed plans to take on more risk, build on advances in life sciences, and expressed optimism in Medicare Advantage, despite missing enrollment targets.

Despite the pandemic maintaining its grip on the economy, 2022 will be another hot year for healthcare.

Global Leader, Health and Life Sciences, Oliver Wyman

Life sciences companies need to be more engaged in building partnerships that promote high-value care.

Global Leader, Health and Life Sciences, Oliver Wyman
Life Sciences Business Leader, Huron

Unleashing latent innovation comes down to commonsense. But not just any commonsense. Radical commonsense.

President and CEO of SCAN Group and Health Plan
Partner, Health and Life Sciences, Oliver Wyman

Imagine a future where leveraging our DNA and what we know about it prevents illness and improves care outcomes.

Co-Founder and CEO, Genome Medical, and 2020 Tom Main Health Innovation Mentorship Winner

Insights in your inbox

Subscribe

With the pandemic accelerating transformation, AMC strategies must reimagine their operations to deliver new value.

Director, Marsh & McLennan Advantage, Healthcare
Partner, Health and Life Sciences, Oliver Wyman
Former Engagement Manager, Oliver Wyman

And How Stakeholders Can, Literally, Save the World

Climate change will be the biggest impact on global health. The healthcare industry may not respond in time.

Director, Marsh & McLennan Advantage Insights
Partner, Health and Life Sciences, Oliver Wyman

Personalized, Proactive, and Smarter Care

AI's capability to detect medical conditions early and accurately will disrupt traditional business models.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

Why Biology Is No Longer Destiny (Or Maybe It Never Was)

Innovations like CRISPR that once seemed more like science fiction are becoming reality. And the business of care delivery is shifting as a result.

Five Healthcare Predictions

2020 was a transformative year. Here's what might happen next with COVID-19, pharmacy cost, telehealth, and more.

Global Leader, Health and Life Sciences, Oliver Wyman
Managing Partner, Americas, Oliver Wyman

Insights in your inbox

Subscribe